Literature DB >> 33933642

Intranasal co-delivery of berberine and evodiamine by self-assembled thermosensitive in-situ hydrogels for improving depressive disorder.

Dong Xu1, Chao Qiu1, Yue Wang1, Tao Qiao1, Yuan-Lu Cui2.   

Abstract

The orally administrated antidepressants not only caused side effects such as dizziness, diarrhea, and drug resistance, but also worked slowly. Therefore, new antidepressants and preparations derived from natural medicines play an important role in the study of antidepressant drugs. It was reported that the two components of Zuojin pill, berberine (BBR) and evodiamine (EVO), were used in combination to improve depressive disorder. In our study, a self-assembled thermosensitive in-situ hydrogel was prepared to achieve sustained co-delivery of BBR and EVO. The preparation process of hydrogel consists of two steps, namely, the inclusion of the drugs and thermosensitive self-assembly of the hydrogel. In vitro experimental results indicated that the prepared hydrogel showed a good thermosensitive property under physiological temperature. The hydrogel had a slow and controlled release behavior for BBR and EVO, according with first-order equation. In vivo experimental results indicated that compared to intragastric administration of drug solution, the intranasal administration of hydrogel increased bioavailability of BBR and EVO, approximately 135 and 112 folds, respectively. The hydrogel at a low dose significantly reversed behavioral despair of the mice, improved depressive symptom of rats, and treated depressive disorder by regulating the abnormal levels of monoamine neurotransmitters (including 5-hydroxytryptamine, noradrenalin and dopamine) metabolism and related metabolic pathways such as purine, citrate cycle, scorbate and aldarate, butanoate, vitamin B6, and pyrimidine metabolism. Therefore, as a drug co-delivery system, the intranasally administrated hydrogels with a good release and high bioavailability provides a non-invasive therapeutic strategy for the clinical treatment of depression, which attains antidepressant effects by regulation of the monoamine neurotransmitters metabolism and related metabolic pathways.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Antidepressant; Berberine; Evodiamine; Hydrogel; Hydroxypropyl-β-cyclodextrin

Year:  2021        PMID: 33933642     DOI: 10.1016/j.ijpharm.2021.120667

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  5 in total

Review 1.  Better Bioactivity, Cerebral Metabolism and Pharmacokinetics of Natural Medicine and Its Advanced Version.

Authors:  Jiaxi Xie; Cailing Zhong; Tingting Wang; Dan He; Luyang Lu; Jie Yang; Ziyi Yuan; Jingqing Zhang
Journal:  Front Pharmacol       Date:  2022-06-27       Impact factor: 5.988

Review 2.  Thermosensitive Hydrogels and Advances in Their Application in Disease Therapy.

Authors:  Ranran Fan; Yi Cheng; Rongrong Wang; Ting Zhang; Hui Zhang; Jianchun Li; Shenghan Song; Aiping Zheng
Journal:  Polymers (Basel)       Date:  2022-06-12       Impact factor: 4.967

3.  Upregulation of SIRT1 by Evodiamine activates PI3K/AKT pathway and blocks intervertebral disc degeneration.

Authors:  Jianbo Kuai; Na Zhang
Journal:  Mol Med Rep       Date:  2022-06-28       Impact factor: 3.423

Review 4.  Current Evidence and Future Directions of Berberine Intervention in Depression.

Authors:  Wen-Qian Zhu; Hui-Ying Wu; Zhi-Hui Sun; Yi Guo; Tong-Tong Ge; Bing-Jin Li; Xin Li; Ran-Ji Cui
Journal:  Front Pharmacol       Date:  2022-05-23       Impact factor: 5.988

5.  Alginate nanogels-based thermosensitive hydrogel to improve antidepressant-like effects of albiflorin via intranasal delivery.

Authors:  Dong Xu; Tao Qiao; Yue Wang; Qiang-Song Wang; Yuan-Lu Cui
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.419

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.